Biotech Values

[onco_investor]

ONCY has a few more followers than you may think

Count me in that camp. Nice 27% move this week and the last month has been pretty good.

BioStockResearch covers ONCY as one of the few select companies in their model Biotech portfolio and newsletter but I wont speak for David.

Granted there are lots of questions that past trials may not have answered to those who require proof from randomized trials but the extensive open label Phase 1 and broad Phase II path ONCY has chosen has positioned it to report up to 4 Phase II trials (NSCLC RAS+, Melanoma, H&N, and maybe Pancreatic)and hopefully a look at the first look point (70 patients) of the randomized Phase III H&N at ASCO next June.

Recent new trials that have started in the last month have been randomized with the NCI paying the bill and patient advocacy groups running the trials. (Ovarian and Pediatric tumors)

There are a lot of vocal parties that criticize the company and its management and some of it is justified however when you are working with a live replication competent virus you are dealing with unchartered science and a little slack is warranted.

In the end viral therapy may or may not work but at this point I see enough evidence of a MOA from trials that demonstrated viral replication in tumours and resolution of distant metastatic liver and colon tumors after treatment with Reolysin to warrant my investment. Should even one indication pan out for this virus, it will be big news.

You can also look to Biovex in MA that is private and working on another viral based treatment that seems to be having similar preliminary results and is running two Phase IIIs right now.

ONCY had a low of $1.00 about 2 years ago and the move to $6.38 Friday shows that there is very strong interest in this stock all of a sudden. These are open label trials running, and if a partnership were going to happen it will most likely be in the next 6 months and from my perspective the time is now to partner because with good results in several trials the need to broaden the clinical program is now.

For those of you open to looking at ONCY, you can do some DD at the ONCY iHub board at:
http://investorshub.advfn.com/boards/board.aspx?board_id=814

My latest post talks about the 37% increase in Institutional ownership in the last 3 months .... MNTA was also mentioned in the same article.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=57594392

cheers
onco_investor